Additional file 3 of Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line

Stella K. Vasiliou (Creator)
Panagiota Filippou Philippou (Creator)
Sergi Clotet-Freixas (Creator)
Antoninus Soosaipillai (Creator)
Ihor Batruch (Creator)
Foivos Viktor Tsianos (Creator)
Ana Konvalinka (Creator)
Eleftherios P. Diamandis (Creator)

Dataset

Description

Additional file 3. Additional Tables S1-S6.

Date made available	2022
Publisher	figshare

DOI
10.6084/m9.figshare.19767724.v1

Access Dataset

Creative Commons Attribution 4.0 International

1 Article

Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line
Vasiliou, SK., Filippou, PS., Clotet-Freixas, S., Soosaipillai, A., Batruch, I., Viktor, T. F., Konvalinka, A. & Diamandis, EP., 14 May 2022, In: Clinical Proteomics. 19, 1, 14.
Research output: Contribution to journal › Article › peer-review

Open Access

Cite this

Vasiliou, S. K. (Creator), Filippou, P. S. (Creator), Clotet-Freixas, S. (Creator), Soosaipillai, A. (Creator), Batruch, I. (Creator), Viktor Tsianos, F. (Creator), Konvalinka, A. (Creator), Diamandis, E. P. (Creator) (2022). Additional file 3 of Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line. figshare. 10.6084/m9.figshare.19767724.v1

Additional file 3 of Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line

Description

DOI

Access Dataset

Research output

Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line

Cite this